the challenges in developing bispecific antibodies for non-hodgkin lymphoma
Published 1 year ago • 201 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:25
advancements and challenges in bispecific antibodies for the treatment of b-nhl
-
2:38
approaching the treatment of patients with lbcl who relapse after bispecific antibodies
-
12:15
car-t vs bispecific antibodies for lymphoma
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
7:46
it's true, i have cancer. non-hodgkin lymphoma!
-
3:51
groundbreaking blood cancer research helping save more lives
-
2:54
non-hodgkin's lymphoma treatment expectations
-
1:54
navigating regulatory challenges in developing and approving therapies for rare lymphomas
-
7:05
developments in the use of bispecific antibodies in myeloma and challenges in this space
-
4:27
the possibility of combining car-t therapy and bispecific antibodies in the treatment of nhl
-
1:34
how will bispecifics impact the treatment of nhl?
-
6:23
the benefits of bispecific antibodies over car-t cell therapy in lymphoma
-
2:03
the next generation of novel agents in development for aggressive b-cell lymphoma
-
2:19
novel treatment options for non-hodgkin lymphoma
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
2:14
the challenges of treating older patients with hodgkin lymphoma
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
2:22
t-cell bispecifics in aml: ongoing challenges and future outlooks
-
3:27
double hit lymphoma: a challenge for lymphoma experts
-
1:45
challenges in mm guideline implementation